Abstract: Peptides previously disclosed as useful for preventing HIV from binding to cell binding sites have now been shown to have thymoleptic qualities and to be useful for tretment of psoriasis in patients who lack antibodies against HIV.
Type:
Grant
Filed:
July 18, 1991
Date of Patent:
September 28, 1993
Assignee:
The United States of America as represented by the Secretary of the Department of Health & Human Services